Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
276.50
+2.29 (0.84%)
Apr 20, 2026, 4:00 PM EDT - Market closed
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $8.14 billion as of April 21, 2026. Its market cap has increased by 58.62% in one year.
Market Cap
8.14B
Enterprise Value
7.19B
1-Year Change
58.62%
Ranking
Category
Stock Price
$276.50
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $8.14B, an increase of 8,708.42%. That is a compound annual growth rate of 68.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 8.08B | 13.06% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 9.54B |
| Bio-Techne | 9.27B |
| Vaxcyte | 8.97B |
| Nuvalent | 8.46B |
| Cytokinetics | 8.22B |
| Halozyme Therapeutics | 8.21B |
| ImmunityBio | 7.95B |
| Kymera Therapeutics | 7.16B |